Multiple Myeloma, MM

Multiple Myeloma, MM

Indicator
IND Enabling
Phase I
Phase II
Phase III
Multiple myeloma, MM (NCT05308875)
Sponsors:
Bioray Laboratories
IND Enabling
Phase I
Phase II
Phase III
Multiple myeloma, MM (NCT05069935)
Sponsors:
Fate Therapeutics 
Indicator
IND Enabling
Phase I
Phase II
Phase III
Multiple myeloma, MM (NCT04960579)
Sponsors:
Poseida Therapeutics, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Multiple Myeloma, MM, (NCT03492268)
Sponsors:
Bioray Laboratories - Bangyao Biotechnology Co., Ltd. 
IND Enabling
Phase I
Phase II
Phase III
Multiple Myeloma, MM, (NCT03752541)
Sponsors:
Bioray Laboratories - Bangyao Biotechnology Co., Ltd. 
IND Enabling
Phase I
Phase II
Phase III
Multiple myeloma, MM (NCT05000450)
Sponsors:
Allogene Therapeutics, Inc.
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Multiple Myeloma, MM, (NCT04171843)
Sponsors:
Precision BioSciences, Inc.
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine